Harriette G C Van Spall1,2, Tahseen Rahman2, Oliver Mytton3, Chinthanie Ramasundarahettige1, Quazi Ibrahim1, Conrad Kabali4, Michiel Coppens5, R Brian Haynes2, Stuart Connolly1. 1. Department of Medicine, McMaster University, and Population Health Research Institute, Hamilton, ON, Canada. 2. Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada. 3. MRC Epidemiology Unit and UKCRC Centre for Diet and Activity Research (CEDAR), University of Cambridge School of Clinical Medicine, Cambridge Biomedical Campus, Cambridge, UK. 4. Division of Epidemiology, Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada. 5. Department of Vascular Medicine, Academic Medical Center, Amsterdam, the Netherlands.
Abstract
AIMS: To compare the effectiveness of transitional care services in decreasing all-cause death and all-cause readmissions following hospitalization for heart failure (HF). METHODS AND RESULTS: We searched PubMed, Embase, CINAHL, and Cochrane Clinical Trials Register for randomized controlled trials (RCTs) published in 2000-2015 that tested the efficacy of transitional care services in patients hospitalized for HF, provided ≥1 month of follow-up, and reported all-cause mortality or all-cause readmissions. Our network meta-analysis included 53 RCTs (12 356 patients). Among services that significantly decreased all-cause mortality compared with usual care, nurse home visits were most effective [ranking P-score 0.6794; relative risk (RR) 0.78, 95% confidence intervals (CI) 0.62-0.98], followed by disease management clinics (DMCs) (ranking P-score 0.6368; RR 0.80, 95% CI 0.67-0.97). Among services that significantly decreased all-cause readmission, nurse home visits were most effective [ranking P-score 0.8365; incident rate ratio (IRR) 0.65, 95% CI 0.49-0.86], followed by nurse case management (NCM) (ranking P-score 0.6168; IRR 0.77, 95% CI 0.63-0.95), and DMCs (ranking P-score 0.5691; IRR 0.80, 95% CI 0.66-0.97). There was no significant difference in the comparative effectiveness of services that improved each outcome. Nurse home visits had the greatest pooled cost-savings (3810 USD, 95% CI 3682-3937), followed by NCM (3435 USD, 95% CI 3224-3645), and DMCs (245 USD, 95% CI -70 to 559). Telephone, telemonitoring, pharmacist, and education interventions did not significantly improve clinical outcomes. CONCLUSION: Nurse home visits and DMCs decrease all-cause mortality after hospitalization for HF. Along with NCM, they also reduce all-cause readmissions, with no significant difference in comparative effectiveness. These services reduce healthcare system costs to varying degrees.
AIMS: To compare the effectiveness of transitional care services in decreasing all-cause death and all-cause readmissions following hospitalization for heart failure (HF). METHODS AND RESULTS: We searched PubMed, Embase, CINAHL, and Cochrane Clinical Trials Register for randomized controlled trials (RCTs) published in 2000-2015 that tested the efficacy of transitional care services in patients hospitalized for HF, provided ≥1 month of follow-up, and reported all-cause mortality or all-cause readmissions. Our network meta-analysis included 53 RCTs (12 356 patients). Among services that significantly decreased all-cause mortality compared with usual care, nurse home visits were most effective [ranking P-score 0.6794; relative risk (RR) 0.78, 95% confidence intervals (CI) 0.62-0.98], followed by disease management clinics (DMCs) (ranking P-score 0.6368; RR 0.80, 95% CI 0.67-0.97). Among services that significantly decreased all-cause readmission, nurse home visits were most effective [ranking P-score 0.8365; incident rate ratio (IRR) 0.65, 95% CI 0.49-0.86], followed by nurse case management (NCM) (ranking P-score 0.6168; IRR 0.77, 95% CI 0.63-0.95), and DMCs (ranking P-score 0.5691; IRR 0.80, 95% CI 0.66-0.97). There was no significant difference in the comparative effectiveness of services that improved each outcome. Nurse home visits had the greatest pooled cost-savings (3810 USD, 95% CI 3682-3937), followed by NCM (3435 USD, 95% CI 3224-3645), and DMCs (245 USD, 95% CI -70 to 559). Telephone, telemonitoring, pharmacist, and education interventions did not significantly improve clinical outcomes. CONCLUSION: Nurse home visits and DMCs decrease all-cause mortality after hospitalization for HF. Along with NCM, they also reduce all-cause readmissions, with no significant difference in comparative effectiveness. These services reduce healthcare system costs to varying degrees.
Authors: Alexander C Razavi; Dominique J Monlezun; Alexander Sapin; Leah Sarris; Emily Schlag; Amber Dyer; Timothy Harlan Journal: Am J Lifestyle Med Date: 2019-07-14
Authors: Ramon Corbalan; Jean-Pierre Bassand; Laura Illingworth; Giuseppe Ambrosio; A John Camm; David A Fitzmaurice; Keith A A Fox; Samuel Z Goldhaber; Shinya Goto; Sylvia Haas; Gloria Kayani; Lorenzo G Mantovani; Frank Misselwitz; Karen S Pieper; Alexander G G Turpie; Freek W A Verheugt; Ajay K Kakkar Journal: JAMA Cardiol Date: 2019-06-01 Impact factor: 14.676
Authors: Nancy L Dawson; Bryan P Hull; Priyanka Vijapura; Adrian G Dumitrascu; Colleen T Ball; Kay M Thiemann; Michael J Maniaci; M Caroline Burton Journal: J Gen Intern Med Date: 2021-01-27 Impact factor: 5.128
Authors: Spyros Kitsiou; Ben S Gerber; Mayank M Kansal; Susan W Buchholz; Jinsong Chen; Todd Ruppar; Jasmine Arrington; Ayomide Owoyemi; Jonathan Leigh; Susan J Pressler Journal: Contemp Clin Trials Date: 2021-05-13 Impact factor: 2.261